JAK Inhibition and Symptom Control in Myeloproliferative Neoplasms

Current Medical Research and Opinion - United Kingdom
doi 10.1080/03007995.2018.1438999
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Informa UK Limited

Related search

DNMT3A Mutations in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Italian Survey on Clinical Practice in Myeloproliferative Neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party Initiative

American Journal of Hematology
Hematology
2019English

Epigenetics and Mutations in Chronic Myeloproliferative Neoplasms

Haematologica
Hematology
2011English

Targeting Glutamine Metabolism in Myeloproliferative Neoplasms

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Myeloproliferative Neoplasms: Morphology and Clinical Practice

American Journal of Hematology
Hematology
2016English

SRSF2 Mutations in Myelodysplasia/Myeloproliferative Neoplasms

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

Histological Evaluation of Myeloproliferative Neoplasms

Journal of clinical and experimental hematopathology : JCEH
Medicine
2018English

New Classification for Myeloproliferative Neoplasms

Cancer Discovery
Oncology
2018English

Targeting Glutamine Metabolism in Myeloproliferative Neoplasms

Blood Cells, Molecules, and Diseases
Molecular MedicineHematologyMolecular BiologyCell Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy